Prelude Capital Management’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-308
Closed -$95.8K 1278
2024
Q1
$95.8K Buy
+308
New +$95.8K 0.01% 1093